E Ronnemaa, B Zethelius, J Sundelof, J … - Neurology, 2008 - AAN Enterprises Results: A low insulin response at baseline was associated with a higher
cumulative risk of AD (hazard ratio for 1 SD decrease, 1.31; 95% CI,
1.10–1.56) also after adjustment for age, systolic blood pressure, body ... Cited by 21 - Related articles - All 4 versions
A Veiraiah - Angiology, 2005 - ang.sagepub.com Hyperlipidemia and its treatment are currently recognized as important
modulators of cardio- vascular mortality in the presence of disordered glucose
control. On the other hand, the effects of hyperglycemia and its treatment ... Cited by 20 - Related articles - BL Direct - All 3 versions
CH Tseng - Archives of Internal Medicine, 2006 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 14 - Related articles - BL Direct - All 7 versions
- ►nih.gov BC Cooper, NZ Burger, MJ Toth, M Cushman, … - American journal of obstetrics and gynecology, 2007 - Elsevier Forty-five postmenopausal women, aged 55 ± 7 years, were examined from a
randomized, double-blind placebo-controlled trial evaluating the effect of HRT
on insulin-stimulated glucose disposal and body composition. Volunteers ... Cited by 14 - Related articles - All 19 versions
US Bedi, S Singh, A Syed, H Aryafar, R Arora - Cardiology in review, 2006 - journals.lww.com Abstract: Coronary artery disease (CAD) is a leading cause of morbidity and
mortality worldwide and was responsible for 7.2 million deaths in 2003. Various
studies have pointed out that South Asians have a higher prevalence of CAD ... Cited by 14 - Related articles - BL Direct - All 4 versions
CA Aguilar-Salinas, R Mehta, R Rojas, FJ … - Current Diabetes Reviews, 2005 - ingentaconnect.com Carlos A. Aguilar-Salinas 1, *, Roopa Mehta 1 , Rosalba Rojas 2 , Francisco J.
Gómez-Pérez 1 , Gustavo ... Olaiz 2 and Juan A. Rull 1 ... 1 Departamento de
Endocrinología y Metabolismo del Instituto Nacional de Ciencias Médicas y ... Cited by 12 - Related articles - BL Direct - All 4 versions
- ►oxfordjournals.org DJ Betteridge, RA DeFronzo, RJ Chilton - European Heart Journal, 2008 - Eur Soc Cardiology The PROspective pioglitAzone Clinical Trial In macroVascular Events (PROactive)
remains the only completed cardiovascular (CV) outcomes study with a
thiazolidinedione. It has provided valuable information on the impact of ... Cited by 12 - Related articles - BL Direct - All 10 versions
JV Patel, KW Lee, J Tomson, K Dubb, EA … - International journal of cardiology, 2007 - Elsevier We investigated the effects of Omacor (a pharmaceutical capsule formulation of
highly refined, concentrated omega-3 PUFA; Solvay Healthcare, Southampton, UK; 1
g/day) in addition to usual care (cardiovascular therapy) in a pilot ... Cited by 8 - Related articles - All 14 versions
NM Lalic, J Maric, M Svetel, A Jotic, E … - Archives of Neurology, 2008 - archneur.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Background Patients with ... Cited by 7 - Related articles - BL Direct - All 3 versions
- ►menopausaitaliana.it [PDF] GJ Goodrow, GD L'Hommedieu, B Gannon, CK … - American journal of obstetrics and gynecology, 2006 - Elsevier Seventy-one nonobese postmenopausal women were assigned randomly to receive
hormone replacement therapy (conjugated estrogens, 0.625 mg, plus
medroxyprogesterone acetate, 2.5 mg) or placebo daily for 1 year (34 women ... Cited by 7 - Related articles - All 19 versions
